BRCA1 and breast cancer: A total of 481 individuals were identified as high-risk BRCA1/2 mutation carriers, with 69.6% (n = 335) representing patients affected by BC and/or OVC, accounting for 9.2% of patients comprehensively screened (132/1,429).